Estrogen receptor in operable breast cancer with negative axillary lymph

Authors

  • Pedro Villar Tejada Departamento de Ginecología y Obstetricia; Departamento de Patología y Cirugía, Hospital Belén, Trujillo, Perú
  • Mariela Zavallos Departamento de Ginecología y Obstetricia; Departamento de Patología y Cirugía, Hospital Belén, Trujillo, Perú
  • Juan Díaz Departamento de Ginecología y Obstetricia; Departamento de Patología y Cirugía, Hospital Belén, Trujillo, Perú
  • Enrique Tantaleán Departamento de Ginecología y Obstetricia; Departamento de Patología y Cirugía, Hospital Belén, Trujillo, Perú
  • Carlos Vilela Departamento de Ginecología y Obstetricia; Departamento de Patología y Cirugía, Hospital Belén, Trujillo, Perú
  • Ravelo Peláez Departamento de Ginecología y Obstetricia; Departamento de Patología y Cirugía, Hospital Belén, Trujillo, Perú

DOI:

https://doi.org/10.31403/rpgo.v46i914

Abstract

OBJECTIVES: To determine the prognostic significance of the state of estrogen receptor (ER) and identify prognostic factors related to the five-year survival in patients with operable breast cancer with negative axillary nodes (CMOGAN). DESIGN: Retrospective. MATERIALS AND METHODS: 37 patients undergoing CMOGAN classical radical mastectomy (n = 28) or modified (n = 9) is evaluated in the Bethlehem Hospital from 1966 to 1995. estrogen receptor status was determined according to immunohistochemical method standard. RESULTS: The mean age was 48 ± 11.1 years. Four cases it had thirty-three stage I and stage II. Seven cases were ER (+) and thirty RE (-). In patients with ER (-) by univariate analysis using the log-rank test, only the type of mastectomy was significantly related to the five-year survival (p = 0.046). In the multivariate Cox analysis, histological grade (p = 0.0361), nuclear grade (p = 0.0361) and miotic index (p = 0.0239) were factors statistically associated with survival. The five-year survival in patients with CMOGAN and RE (+) was 100% and in patients RE (-) 65%. CONCLUSION: The histological and nuclear grade, and mitotic index significantly influence the survival of patients with CMOGAN and RE (-).

Downloads

Download data is not yet available.

Published

2015-06-14

How to Cite

Villar Tejada, P., Zavallos, M., Díaz, J., Tantaleán, E., Vilela, C., & Peláez, R. (2015). Estrogen receptor in operable breast cancer with negative axillary lymph. The Peruvian Journal of Gynecology and Obstetrics, 46(4), 303–311. https://doi.org/10.31403/rpgo.v46i914

Issue

Section

Artículos Originales

Most read articles by the same author(s)